Enter your username/e-mail and your new password will be send to you.

Project

INFRAVEC

Title Research Capacity for the Implementation of Genetic Control of Mosquitoes
Grant Agreement Number 228421
Funding Programmes FP7
Dates 01/09/2009 - 31/08/2013
Project URL http://www.infravec.eu
Scientific Domain Biological and Medical Sciences
Activity Integrating activities
Action Line Integrated Activity
Transnational Access Yes
Type Of Project CP-CSA-INFRA
Abstract Mosquitoes transmit a variety of infectious diseases that cause a tremendous burden to public health. Due to climate changes and to the increase in international trade and tourism the threats posed by mosquitoes are increasingly affecting large parts of Europe, causing understandable concerns among the populations of many Member States. Control methods, mainly based on insecticide usage, are struggling to cope with the challenges posed by the biology and ecology of mosquito vectors. INFRAVEC aims at bridging the gap between the recent advances in transgenic technology and its implementation as a novel powerful approach for vector control. To this aim, a large European Infrastructure will be established, in which the coordination of efforts, expertise and facilities provided by the individual research groups and institutions will bolster and considerably expand the overall research capabilities of the research community. INFRAVEC will operate, through a number of Networking, Joint Research, Transnational and Service activities, towards the objective of considerably strengthening research capability in Europe by sharing knowledge, resources and technology. INFRAVEC will mainly focus on Anopheles gambiae, the major vector of malaria, and Aedes albopictus, a viral disease vector that is rapidly spreading through Europe. Four Infrastructure facilities will be integrated in the project: 1) the Genetically Modified mosquito laboratory of Imperial College London; 2) the Mosquito Mass-rearing facility at the Centro Agricoltura ed Ambiente (with the support of the International Atomic Energy Agency); 3) the Bioinformatics facility at EMBLEBI, UK; and 4) the Mosquito Confined Release facility at ISRIM. INFRAVEC will provide a formidable research capability to external users and facilitate the performance of five research projects aimed at utilizing basic knowledge of mosquito genetics and biology in an unprecedented effort to develop novel opportunities for mosquito control.
Partners
(Organisation name and Country)
UNIVERSITY OF GLASGOW, United Kingdom
STOCKHOLMS UNIVERSITET, Sweden
INSTITUT PASTEUR, France
UNIVERSITA DEGLI STUDI DI PERUGIA, Italy
Oxitec Limited, United Kingdom
UNIVERSITAETSKLINIKUM HEIDELBERG, Germany
MED BIOTECH LABORATORIES, Uganda
ISTITUTO SUPERIORE DI SANITA, Italy
UNIVERSITA DEGLI STUDI DI CAMERINO, Italy
Organisation de Coordination pour la lutte contre les Endémies en Afrique Centrale, Cameroon
UNIVERSITY OF KEELE, United Kingdom
ISTITUTO SUPERIORE DI RICERCA E FORMAZIONE SUI MATERIALI SPECIALI PERTECNOLOGIE AVANZATE SCRL IN BREVE ISRIMS CONS A R L, Italy
CENTRE NATIONAL DE RECHERCHE SCIENTIFIQUE ET TECHNOLOGIQUE*INSTITUT DE RECHERCHE EN SCIENCES DE LA SANTE, Burkina Faso
INSTITUT PASTEUR DE DAKAR, Senegal
INSTITUTO DE HIGIENE E MEDICINA TROPICAL, Portugal
International Centre of Insect Physiology and Ecology, Kenya
MINISTERE DE LA SANTE, Burkina Faso
CENTRO AGRICOLTURA E AMBIENTE GIORGIO NICOLI SRL, Italy
AGRICULTURAL UNIVERSITY OF ATHENS, Greece
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS, Greece
STICHTING KATHOLIEKE UNIVERSITEIT, Netherlands
UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II., Italy
WAGENINGEN UNIVERSITY, Netherlands
LIVERPOOL SCHOOL OF TROPICAL MEDICINE, United Kingdom
UNIVERSITA DEGLI STUDI DI PAVIA, Italy
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA, Italy
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD, United Kingdom
TA Call Research Capacity for the Implementation of Genetic Control of Mosquitoes